HCA Healthcare, Inc. (NYSE:HCA) Holdings Raised by Resona Asset Management Co. Ltd.

Key Points

• Resona Asset Management Co. Ltd. increased its stake in HCA Healthcare by 7.2%, acquiring an additional 4,152 shares and bringing its total holdings to 61,953 shares valued at approximately $21.37 million.
• Various institutional investors have significantly raised their positions in HCA Healthcare, with GAMMA Investing LLC growing its holdings by an astonishing 40,527.3% in the first quarter.
• The company reported earnings per share of $6.84, surpassing estimates, and announced a quarterly dividend of $0.72, indicating a dividend yield of 0.7% as of the latest reporting period.

Resona Asset Management Co. Ltd. raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 7.2% in the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 61,953 shares of the company's stock after buying an additional 4,152 shares during the quarter. Resona Asset Management Co. Ltd.'s holdings in HCA Healthcare were worth $21,374,000 at the end of the most recent reporting period.

A number of other large investors have also made changes to their positions in the business. Avantax Advisory Services Inc. boosted its holdings in HCA Healthcare by 0.4% in the first quarter. Avantax Advisory Services Inc. now owns 8,077 shares of the company's stock worth $2,791,000 after acquiring an additional 32 shares in the last quarter. Catalyst Financial Partners LLC boosted its holdings in shares of HCA Healthcare by 4.3% in the 1st quarter. Catalyst Financial Partners LLC now owns 872 shares of the company's stock valued at $301,000 after acquiring an additional 36 shares during the last quarter. Moors & Cabot Inc. raised its holdings in shares of HCA Healthcare by 4.8% during the first quarter. Moors & Cabot Inc. now owns 858 shares of the company's stock worth $297,000 after purchasing an additional 39 shares during the last quarter. Perigon Wealth Management LLC grew its position in HCA Healthcare by 2.3% during the 1st quarter. Perigon Wealth Management LLC now owns 1,797 shares of the company's stock worth $621,000 after purchasing an additional 40 shares during the period. Finally, Barden Capital Management Inc. boosted its stake in shares of HCA Healthcare by 1.4% in the first quarter. Barden Capital Management Inc. now owns 2,921 shares of the company's stock worth $1,009,000 after buying an additional 41 shares during the last quarter. 62.73% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several research analysts have recently weighed in on HCA shares. Royal Bank Of Canada reduced their target price on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Wolfe Research lowered shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Wells Fargo & Company reduced their target price on shares of HCA Healthcare from $385.00 to $375.00 and set an "equal weight" rating on the stock in a report on Thursday. Morgan Stanley reduced their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a report on Monday, July 28th. Finally, Truist Financial lifted their price target on HCA Healthcare from $390.00 to $415.00 and gave the stock a "buy" rating in a report on Wednesday, July 16th. Nine research analysts have rated the stock with a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $398.58.

HCA Healthcare Stock Performance

NYSE:HCA traded up $2.18 during midday trading on Friday, reaching $395.83. The stock had a trading volume of 1,251,407 shares, compared to its average volume of 1,577,483. The stock has a market cap of $92.62 billion, a P/E ratio of 16.64, a P/E/G ratio of 1.23 and a beta of 1.39. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The firm has a fifty day simple moving average of $370.31 and a two-hundred day simple moving average of $351.00. HCA Healthcare, Inc. has a 12-month low of $289.98 and a 12-month high of $417.14.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings results on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. The business had revenue of $18.61 billion for the quarter, compared to analyst estimates of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's quarterly revenue was up 6.4% on a year-over-year basis. During the same period in the prior year, the business earned $5.50 earnings per share. On average, equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be given a $0.72 dividend. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.